NGL Fine-Chem stock | Growth outlook for 2026 & price target

NGL Fine-Chem

BSE:524774

Rp 2.071,15

Rp-50,80 (-2,39%)

2.071,15 Rp

Rp-50,80 (-2,39%)

End-of-day quote: 03/30/2026

NGL Fine-Chem Stock Value

The current analyst rating for BSE:524774 is Buy.

Buy

NGL Fine-Chem Company Info

EPS Growth 5Y

-3,48%

Market Cap

Rp13,11 B

Long-Term Debt

Rp0,25 B

Annual earnings

05/12/2026 (E)

Dividend

Rp1,66

Dividend Yield

0,08%

Founded

1981

Industry

Materials

Country

India

Website

NGL Fine-Chem

ISIN Number

INE887E01022

Website

http://www.nglfinechem.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, NGL Fine-Chem’s Price Target has risen from Rp290,00 to Rp290,00 - a 0,00% increase.

Top growth stocks in the materials sector (5Y.)

What does NGL Fine-Chem do?

NGL Fine-Chem Limited engages in manufacturing pharmaceuticals, medicinal, and chemical products Business Segments The company operates through pharmaceutical and chemical manufacturing segments. The pharmaceutical segment is where the company gains significant traction, producing active pharmaceutical ingredients (APIs) and intermediates that cater to a wide array of applications and comply with various regulatory requirements. The company’s product portfolio includes custom synthesis servi...

NGL Fine-Chem Limited engages in manufacturing pharmaceuticals, medicinal, and chemical products

Business Segments

The company operates through pharmaceutical and chemical manufacturing segments.

The pharmaceutical segment is where the company gains significant traction, producing active pharmaceutical ingredients (APIs) and intermediates that cater to a wide array of applications and comply with various regulatory requirements.

The company’s product portfolio includes custom synthesis services, where the company collaborates with partners to develop tailored solutions based on their unique needs.

Business Strategy

The company’s business strategy revolves around sustainable growth, innovation, and maintaining a strong focus on quality and safety. The company aims to enhance operational efficiencies through investment in advanced technologies and processes that promote not only product innovation but also environmental responsibility.

At the core of the company’s strategy is its commitment to safety and regulatory compliance. The company ensures that all its production processes adhere to strict national and international standards.

The company acknowledges the importance of collaboration with industry partners and clients to foster a progressive ecosystem that promotes shared growth.

In addition to pursuing new market opportunities, the company is dedicated to enhancing its operational capacity. This dedication is reflected in its willingness to invest in the latest technologies and, where necessary, explore strategic acquisitions to broaden its portfolio and market reach.

Products and Services

The company offers a wide-ranging portfolio of products primarily targeted at the pharmaceutical, medicinal, and chemical manufacturing sectors. The cornerstone of its offerings includes active pharmaceutical ingredients (APIs) and intermediates, which are essential for producing a variety of therapeutic products.

In addition to APIs, the company provides custom synthesis services.

Geographical Markets Served

The company serves a diverse array of geographical markets, operating on a pan-India basis while catering to clients in over 51 countries worldwide. The company has strategically positioned itself to capitalize on the growing global demand for pharmaceutical ingredients, emphasizing export capabilities which have contributed significantly to its overall turnover.

Customers

The company boasts a diverse customer base that includes various global pharmaceutical companies engaged in the manufacture of custom, high-quality products. The clientele spans over 51 countries, encompassing large manufacturers, small and medium enterprises, and specialty pharmaceutical companies.

Modes of Sales and Marketing/ Marketing/Distribution Channels

The company employs various sales and marketing strategies to promote its products and services. The company primarily uses direct marketing methods, engaging with clients through industry-specific channels, trade shows, and online platforms.

Additionally, the company’s distribution channels are well-structured to ensure timely delivery and responsive service. Attention to logistics and customer feedback plays a vital role in refining the marketing approach, aligning the company’s goals with clients' needs.

Environmental Laws

The company operates in stringent regulatory environments, ensuring compliance with national and international laws governing the pharmaceutical and chemical manufacturing sectors. The company adheres to high environmental standards, following relevant laws such as the Prevention and Control of Pollution Act and Environment Protection Act.

History

NGL Fine-Chem Limited was founded in 1981. The company was incorporated in 1981.

New support ticket

Explore

NGL Fine-Chem Stock Value

NGL Fine-Chem Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does NGL Fine-Chem do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

NGL Fine-Chem Stock Value

NGL Fine-Chem Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does NGL Fine-Chem do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.